Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-25 @ 9:30 PM
Study NCT ID:
NCT07142551
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-08-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-08-19
First Submit QC Date:
None
Study First Post Date:
2025-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-10
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED